The Oxford Optimisation of PCI Study (OXOPT-PCI Study) — OXOPT-PCI  

Coronary Artery Disease Clinical Trial

Official title: The Oxford Optimisation of PCI Study (OXOPT-PCI Study)

Status Completed

Clinical Trial Summary

The OxOPT-PCI study addresses patients with coronary artery disease who are referred to the John Radcliffe Hospital because of the need for treatment with an intra-coronary stent (metal scaffold) for clinical reasons. Although, this has become a highly standardised procedure it is still challenging for the clinician to assess the final success of this procedure at the end of intervention with conventional methods. This shortcoming can potentially translate into a worse clinical outcome for approximately 10 percent of all patients treated with an intra-coronary stent for this type of disease.

This study (OxOPT-PCI) investigates if the use of blood flow measurements (namely measurement of fractional flow reserve (FFR)) and intravascular imaging (namely optical coherence tomography (OCT)) after the implantation of a stent can improve the treatment result for these patients. Both, FFR and OCT are being used already in daily clinical routing but their usefulness especially in combination is not clear. In order to standardise the optimisation procedure we developed a specific algorithm to make sure that all patients receive the same optimisation measures based on the assessment of FFR and OCT.

The benefit of this specific optimisation algorithm will be assessed by measuring 1) indices of coronary blood flow, 2) intravascular imaging at the end of the procedure, and 3) by contacting the patients 12 months after stenting to verify the clinical mid-term success.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Coronary Artery Disease

• NCT number: NCT03111940
• Study type: Interventional
• Source: Oxford University Hospitals NHS Trust
• Status: Completed
• Phase: N/A
• Start date: August 2016
• Completion date: July 2017